New Delhi, September 2: The Drug Controller General of India has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots called Corbevax on children.
The trial will be on children between 5 and 18 years of age with certain conditions.
The trial will be conducted in ten locations across the country.
|